Clinical Trials Directory

Trials / Completed

CompletedNCT03029936

Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence

Obesity-asthma Endophenotype: Assessment of Diaphragm Mobility and Muscle Inflammation Markers in the Adolescence

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Universidade Federal de Pernambuco · Academic / Other
Sex
All
Age
12 Years – 21 Years
Healthy volunteers
Accepted

Summary

Obesity and asthma share changes that may begin in the fetal development phase. The endophenotype obesity-asthma presents as main characteristic a pattern of inflammatory response different from the habitual Th2 profile of cytokines. In these obese patients, possible changes in the diaphragm muscle can directly influence the dynamics of pulmonary ventilation significantly. Due to the importance of the diaphragm in pulmonary ventilation, this study will be performed to verify possible alteration in the excursion and diaphragmatic thickness of adolescents with endophenotype obesity-asthma. In parallel, the possible underlying etiopathogenic substrate of this endophenotype will be explored through the dosing of muscle enzymes and inflammatory cytokines and obesity hormones.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2017-07-30
Completion
2017-12-01
First posted
2017-01-24
Last updated
2018-03-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03029936. Inclusion in this directory is not an endorsement.

Obesity-asthma Endophenotype and Diaphragm Mobility in Adolescence (NCT03029936) · Clinical Trials Directory